Skip to main content
. 2009 Apr 23;32(7):1196–1198. doi: 10.2337/dc08-2259

Table 1.

Subject characteristics

Hypoglycemia unaware Hypoglycemia aware P
n 19 31
Duration of observation (days) 419 ± 139 568 ± 255 0.024
Age (years) 47.5 ± 11.4 36.1 ± 10.2 0.001
Sex (% female) 52.6 (10) 71.0 (22) 0.190
Duration type 1 diabetes (years) 32.1 ± 12.9 20.5 ± 11.3 0.002
Weight (kg) 70.4 ± 16.2 73.7 ± 13.3 0.449
BMI 25.0 ± 5.0 26.1 ± 4.0 0.401
% Who did not attend 7.5 ± 11.4 12.3 ± 12.4 0.174
% Completed DAFNE 47.4 (9) 61.3 (19) 0.336
% Psychiatric history 10.5 (2) 29.2 (7) 0.282
% Cognitive behavioral therapy 10.5 (2) 24.0 (6) 0.409
% Retinopathy (any degree on retinal photography)* 55.6 (10) 61.3 (19) 0.694
% Nephropathy (microalbuminuria/ proteinuria)* 10.5 (2) 29.0 (9) 0.125
% Neuropathy (symptoms or sensory loss)* 21.1 (4) 9.7 (3) 0.261
A1C (%) 7.2 ± 0.7 8.3 ± 1.3 0.007
Insulin dose (units · kg−1 · day−1) 0.59 ± 0.16 0.77 ± 0.26 0.030

*Taken from annual review data during audit period. DAFNE, Dose Adjustment for Normal Eating, a 5-day structured education program in flexible insulin therapy for type 1 diabetic patients.